The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and total costs of care.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
Commentary and analysis from Milbank Memorial Fund President Christoper F. Koller.
December 2016
In the aftermath of the November elections, we at the Fund had a chance to speak in person to over 125 state health policy leaders as we held meetings… More
November 2016
Congress is preparing to debate the future of the Affordable Care Act (ACA) yet again. While “repeal and replace” may take longer than was… More
October 2016
The release on October 17, 2016 of 2015 Shared Savings and Quality Results for year two of the Center for Medicare and Medicaid Innovation’s (CMMI)… More
September 2016
What does it take to have stable, competitive health insurance markets? I was recently asked this question by the Senate Homeland Security and… More
August 2016
Ricky may have been on the edge of losing control, but he was still teaching me some health policy lessons. Word was out among his friends that… More
July 2016
I have a new emergency room (ER) drama for television in mind. In my TV drama, there are no sirens and no gurneys racing through the corridors. There… More
June 2016
With threats of lawsuits and pressure from government officials, some payers appear to be relaxing their coverage guidelines for expensive direct-acting antiviral drugs (DAAs), including drugs for Hepatitis C. More
May 2016
If I die before my time, is it my fault? If I drank a lot of alcohol, drove too fast, didn’t wear a seat belt, and crashed—most would say yes, I had it coming. If I got hit by that driver while walking on the sidewalk, it would be a terrible tragedy. What about groups of people who die early? More
April 2016
My e-mail inbox is full of innovations—solicitations for health care meetings, most offering “unique opportunities” to hear from “national leaders,” all of whom are busy innovating. Much of the conference fodder focuses on payment reform. More
March 2016
We are not the first country to wrestle with the effects of fee-for-service medicine, it seems. I recently picked up the book, The Forging of a Rebel, an autobiography of Spanish Civil War veteran Arturo Barea—and encountered the durable power of economic incentives in medical care. More
